EPT , telehealth company .
I'll let others to research (and wont spell out what it does here in this thread) but if you want refer to the announcements made in June and July 2017 the investor presentation about what it is, and the announcement in July 2017 of regulatory approval granted for Australia (TGA) and Europe (CE), along with strategic partnership with Nviso. It also had a peer reviewed study journal article published (no mean feat)
Then refer back to Oct-2016 when it backdoor listed from MNQ for the prospectus page 33 where it states regulatory approval in Q3-2017, which it achieved in the first month of Q3!!!!.
FDA is planned 2018.
Also earlier investor presentations from earlier in the year described the timeline for commercialisation of the app in Q4-17 which has been re-iterated in the latest investor presentation of July-17 as still being the case, and reinforced by management communication.
Timelines can be achieved by management in spec companies, rare but possible.
- Forums
- ASX - By Stock
- RAP
- Ann: Voluntary Suspension
Ann: Voluntary Suspension, page-190
-
-
- There are more pages in this discussion • 282 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)